Depletion of SHOC2 blocks RTK-mediated ERK activation and causes synthetic lethal with MEKi in KRAS mutant PDAC and NSCLC cells 111 and with RAFi in BRAF mutant CRC cells 138. Here, KRAS is linked to non-small cell lung carcinoma.